Evoke Pharma Inc reports results for the quarter ended in June - Earnings Summary

Evoke Pharma

12/08/2021 22:02

* Evoke Pharma Inc  EVOK.OQ  reported a quarterly adjusted loss
of 7 cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 8 cents per
share.
* Revenue was $236.64 thousand​;  analysts expected $151.00
thousand. 
* The mean earnings estimate of analysts had fallen by
about 33.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Evoke Pharma Inc shares had fallen by 16.8% this quarter and
lost 55.8% so far this year.
* The company reported a quarterly loss of $2.29 million.
* Wall Street's median 12-month price target for Evoke Pharma
Inc is $9.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 09:02 p.m.  ​All
figures in US dollars unless otherwise stated